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Abstract
Background: Pancreatic islets are not fully developed at birth and it is not clear how they are
vascularised and innervated. Nerve Growth Factor (NGF) is required to guide sympathetic neurons
that innervate peripheral organs and also in cardiovascular system and ovary angiogenesis.
Pancreatic beta cells of a transgenic mouse that over-expressed NGF in attracts sympathetic hyper-
innervation towards them. Moreover, we have previously demonstrated that adult beta cells
synthesize and secrete NGF; however, we do not know how is NGF secreted during development,
nor if it might be trophic for sympathetic innervation and survival in the pancreas.
We analyzed sympathetic innervation and vasculature development in rat pancreatic islets at
different developmental stages; foetal (F19), early postnatal (P1), weaning period (P20) and adults.
We temporarily correlated these events to NGF secretion by islet cells.
Results: Sympathetic fibres reached pancreatic islets in the early postnatal period, apparently
following blood vessels. The maximal number of sympathetic fibres (TH immunopositive) in the
periphery of the islets was observed at P20, and then fibres entered the islets and reached the core
where beta cells are mainly located. The number of fibres decreased from that stage to adulthood.
At all stages studied, islet cells secreted NGF and also expressed the high affinity receptor TrkA.
Foetal and neonatal isolated islet cells secreted more NGF than adults. TrkA receptors were
expressed at all stages in pancreatic sympathetic fibres and blood vessels. These last structures
were NGF–immunoreactive only at early stages (foetal and P0).
Conclusion: The results suggest that NGF signalling play an important role in the guidance of
blood vessels and sympathetic fibres toward the islets during foetal and neonatal stages and could
also preserve innervation at later stages of life.
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Background
Adult pancreatic b cells secrete insulin in response to an
increase in extracellular glucose. At birth, this response is
not fully developed as neonate b-cells are insensitive to
glucose and synthesize and secrete less insulin than adults
[1]. Pancreatic islets are innervated by autonomic fibres.
In particular, sympathetic neural cell bodies are located in
the superior mesenteric and celiac ganglia and are compo-
nents of the splanchnic nerve and parasympathetic inner-
vation comes from the vagus nerve [2].
Sympathetic innervation plays important roles in the
physiology and physiopathology of the endocrine pan-
creas; nor- and epinephrine inhibit insulin secretion,
while stimulate glucagon secretion [3]. Moreover, sympa-
thetic innervation of pancreatic islets is altered in animal
models with insulin resistance and type 2 diabetes [4].
However, factors that control sympathetic innervation of
pancreatic islets are not clear. The neurotrophin nerve
growth factor (NGF) is especially interesting because is
synthesized by the peripheral targets of NGF-dependent
sympathetic neurons and NGF concentrations are propor-
tional to their innervation density [5]. For example, NGF
participates in the innervation of spleen, peripheral
lymph nodes and ovaries [6-8] and has also trophic effects
on their vascularization [9].
Adult pancreatic beta cells produce and secrete NGF and
express NGF high- (TrkA) and low-affinity (p75) receptors
during lifespan and NGF is important for a normal islet
morphogenesis during prenatal life [10,11] and have
trophic effects on b cells survival, maturation and insulin
secretion [1,12-14]. These effects are controlled by auto-
crine or paracrine mechanisms [15].
Sympathetic nerves in the pancreas are closely related to
blood vessels [16], and nervous fibres are also in part
guided by endothelium-derived signals [17]. Trophic
interactions among nerve cells, blood vessels and islet
cells are fundamental to assure an adequate pancreatic
ontogeny and a mature assemblage and function.
NGF could be an important regulator molecule on inner-
vation and vascularisation of the islets. The following
observations indicate that this could be the case, 1) NGF
overexpression in pancreatic b cells causes islet sympa-
thetic hyper-innervation [18]. 2) When islet grafts to dia-
betic rats are pre-treated with NGF, sympathetic
innervation is increased after transplantation [19]. 3) Pan-
creatic sympathetic innervation is reduced in NGF/Bax
double knockout (KO) mice [20]. Finally, NGF in vitro
induces development of glucose-induced insulin secre-
tion in neonate rat b cells [14] and promotes neuron-like
phenotypic changes in foetal and adult b cells [21]. The
aim of this study was to investigate the morphophysiolog-
ical relationships between innervation, vascularization
and islet morphogenesis and function during ontogeny of
rat pancreas, in particular of islets from foetal (F19), early
(P1) and late postnatal (P20) stages of development,
compared to adults. We also analyzed biosynthesis and
secretion of NGF and insulin by b cells at these stages.
Results
The structure of pancreatic islets during ontogeny
As expected, in mature adult islets glucagon producing b
cells form a ring-like structure, surrounding insulin-pro-
ducing b cells that fill most of the centre (Fig. 1D and 1H).
At this stage, we observed that 98% of islets were delim-
ited by a collagen capsule (Fig. 1H and additional file 1).
Morphological reorganization of pancreatic islets from prenatal life to adulthood Figure 1
Morphological reorganization of pancreatic islets from prenatal life to adulthood. We localised sympathetic nerve 
fibres and collagen capsules surrounding the islets by confocal microscopy in longitudinal sections of pancreases. Immunostain-
ing for insulin (green), glucagon (blue), tyrosine hydroxylase (TH; red) and collagen type IV (2nd line, green) at different develop-
mental stages (F19, P1, P20 and adult). Scale bar = 50 mm.BMC Developmental Biology 2009, 9:34 http://www.biomedcentral.com/1471-213X/9/34
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In contrast, F19 islets were not formed yet; we only
observed large groups of endocrine cells without a capsule
and isolated a and b cells were scattered through the exo-
crine pancreas (Fig. 1A and 1E and additional file 1). Neo-
natal islets were small, rounded, did not yet presented
capsule and were located in close proximity to each other
(Fig. 1B and 1F and additional file 1). At P20 most of the
endocrine cells had a similar distribution to adults; how-
ever, only nearly 26% of the islets were encapsulated (Fig.
1C and 1G and additional file 1).
Remodelling sympathetic innervation of islets and NGF
To identify the sympathetic fibres we used a tyrosine-
hydroxylase (TH) immunofluorescence. A progressive
increase in the relative area occupied by TH positive inner-
vation in the islets was observed between F19 to P20 (Fig.
1 upper panels and Fig 2A). Interestingly, this parameter
decreased between P20 and adulthood in the periphery of
the islets (Fig. 1 upper panels and Fig. 2B), while increased
in the central area (Fig. 1, upper panels and Fig. 2C).
Sympathetic remodelling in this process is probably mod-
ulated by NGF produced by islet cells. We analyzed NGF
production in situ with an antibody raised against the
NGF precursor protein pro-NGF [22-24] in a and b cells.
Pro-NGF immunoreactivity was observed in both cell
types at all stages studied (Fig. 3A and 3B). However, the
fluorescence intensity was higher at F19 and P1 than at
later ontogenetic stages (additional file 2A and 2B) and
when this was studied in isolated islet cells, we confirmed
that most of them were b cells (insulin positive) and also
labelled positive for TrkA receptors (additional file 3). At
all stages studied mRNA for NGF is expressed by islet cells
(data not shown).
NGF is released by foetal and neonatal islet cells
We analyzed NGF secretion by ELISA (see Methods). At all
studied stages, islet cells secreted NGF (Figure 4A). In
accordance to the pro-NGF immunofluorescence
observed; NGF secretion was higher at F19 and P1 than at
older ages.
NGF secretion may be constitutive or regulated by other
way than glucose stimulated insulin secretion, because
clearly from figure 4B, both types of secretions are disso-
ciated. This effect can not be attributed to cultured condi-
tions or reduced cell viability, because P20 and adult
cultured b cells increased insulin secretion when exposed
to high glucose and KCl. Under the last experimental con-
dition, adult b cells also increased NGF release.
Pro-NGF and TrkA receptors are expressed for a delimited 
period in vascular cells
Vascular cells may also provide guidance cues to axons in
their way to reach their targets [17]. Figure 5 shows that
blood vessels that enter the islets early in pancreatic
ontogeny (F19 and P1) labelled positive to pro-NGF, but
not at P20 and thereafter (Fig. 6A and 6B). Blood vessels
and sympathetic fibres can respond to NGF, because clear
and consistently at all stages both vascular cells and TH
positive fibres display immunoreactivity for TrkA recep-
tors (Fig. 7A and 7B).
Quantification and analysis of TH+ fibres in development of  islets Figure 2
Quantification and analysis of TH+ fibres in develop-
ment of islets. Bar graphs represent A) Percentage of total 
area occupied by TH+ fibres. B) Percentage of peripheral area 
occupied by TH+ fibres. C) Percentage of the core area occu-
pied by TH+ fibres. ANOVA *p < 0.001 compared to adult-
hood.BMC Developmental Biology 2009, 9:34 http://www.biomedcentral.com/1471-213X/9/34
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Discussion
We analyzed innervation and function development of
pancreatic islets. To our knowledge this is the first analysis
of the relationship between innervation, blood vessels
and rat pancreatic islets morphology at critical develop-
mental stages. We also examined a possible role of NGF in
this process.
Glucose homeostasis in foetal stages depends on the
mother [25]. At birth, mammals abruptly need to achieve
glucose control on their own, so b cells start secreting
insulin. Nearly at P20 pups are weaned and they build up
an omnivorous diet. These two stages are critical windows
for pancreatic development and maturation of glucose
induced insulin secretion [1,26]. We propose that a cap-
sule or basal membrane surrounding the islets may be
taken as one of the maturity markers, because almost all
mature islets in adult animals are surrounded by one. It
has been suggested that a membrane surrounding the
islets could be an important niche for their complete
development and survival [27-29]. We observed that a
nearly-mature configuration of the pancreatic islets is pro-
gressively established during the first 20 days of posnatal
life in the rat. However, at this stage nearly 30% of islets
presented a continuous capsule surrounding them, indi-
cating that they will continue maturing until adulthood
[26].
We observed that pancreatic islets in early development
receive an extensive innervation by sympathetic fibres.
This innervation is refined later in development. Interest-
ingly, when islets are transplanted to the kidney capsule or
intraportally, they develop sympathetic innervation after
transplantation [30,31]. Moreover, when purified b cells
are transplanted to the kidney capsule, grafts are progres-
sively innervated mainly by tyrosine hydroxylase-contain-
ing nerve fibres. These observations led to suggest that
some factors produced by b cells mediate islet neurotro-
phism [31].
We have previously shown that adult pancreatic b cells
produce and secrete NGF [15]. In this work we observed
that this is the case also along ontogeny, which indicates
that NGF may be trophic for sympathetic innervation and
survival in islets, as it has been observed for other organs
[6-8]. NGF secretion in adult cells could also be important
for sympathetic fibres maintenance throughout life.
Vascular cells also displayed pro-NGF immunoreactivity,
however this is only observed in a critical window around
Colocalization of pro-NGF and insulin or glucagon Figure 3
Colocalization of pro-NGF and insulin or glucagon. (A) Insulin and pro-NGF, (B) glucagon and pro-NGF at different 
developmental stages. Scale bar = 20 mm.BMC Developmental Biology 2009, 9:34 http://www.biomedcentral.com/1471-213X/9/34
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birth. This could also be important for nerve guidance
into the islets. There is no perfect marker for blood vessels.
We used isolectin IB4 and vimentin. Vimentin expression
alone cannot be considered as specific endothelium
marker; but it seems to accompany the process of angio-
genesis in islets [32]. We also observed that both markers
were expressed in blood vessels of developing and mature
islets.
NGF produced by b, a and vascular cells might be acting
by auto/paracrine mechanisms because all the studied
cells within the islets express TrkA receptors. During devel-
opment NGF may attract sympathetic fibres as they search
for their targets as described for artemin [17,33] and/or
promote sympathetic fibre outgrowth within the islet. The
presence of TrkA receptors in b cells is not new [10,15,34].
It is likely that NGF acting through autocrine/paracrine
mechanisms promotes b cell maturation. In support of
this possibility, it has been shown that glucose-induced
insulin secretion is increased by NGF after calcium chan-
nel translocation to the membrane of the neonate rat b
cells [35]. The presence of TrkA receptors in vascular cells,
on the other hand, might be important for islet blood ves-
sel development because NGF also promotes angiogen-
esis [9,36] and migration of endothelial cell [37].
NGF and insulin secretion at different stages of development Figure 4
NGF and insulin secretion at different stages of development. Bar graphs represent NGF (A) or insulin (B) secretion 
by isolated insular cells under basal or stimulated conditions at different developmental stages. Line 1) Basal 5.6 mM glucose; 2) 
Stimulated 15.6 mM glucose and 3) Glucose 15.6 mM plus 20 mM KCl. ANOVA *p < 0.001 compared to adult cells. Data 
obtained from 4 independent experiments, each by duplicate.
Blood vessel localization in rat islets during development Figure 5
Blood vessel localization in rat islets during develop-
ment. Insulin (green); Iso-lectin IB4 (red); merge (yellow). 
Scale bar = 50 mm.BMC Developmental Biology 2009, 9:34 http://www.biomedcentral.com/1471-213X/9/34
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Expression of TrkA in vascular cells and sympathetic fibres of pancreatic islets Figure 7
Expression of TrkA in vascular cells and sympathetic fibres of pancreatic islets. (A) Colocalization of TrkA and 
vimentin; (B) TrkA and TH at different ontogenetic stages. Colocalization of markers in blood vessels (c, f, i and l) or sympa-
thetic fibres (o, r, u and x). Scale bar = 20 mm.
Pro-NGF expression in vascular cells of pancreatic islets Figure 6
Pro-NGF expression in vascular cells of pancreatic islets. (A) Colocalization of pro-NGF and vimentin (c and f), (B) 
pro-NGF and lectin IB4 in different ontogenetic stages (o and r). Scale bar = 20 mm.BMC Developmental Biology 2009, 9:34 http://www.biomedcentral.com/1471-213X/9/34
Page 7 of 11
(page number not for citation purposes)
These results show that sympathetic innervation is sub-
jected to a strong ontogenetic remodelling during pancre-
atic development. In general terms, there is a trend of
innervation to increase from the perinatal period to P20.
After this time, the amount of innervation within the islet
decreases. Early hyper-innervation followed by a late
elimination of redundant axons mediated through com-
petitive interactions is commonly seen in peripheral tar-
gets [38,39]. However, it is to our knowledge the first
description in pancreatic islets.
At earlier stages, sympathetic fibres are located mainly to
the periphery of the islets or a cell compartment and as
islets mature, an adjustment in the amount of fibres is
accompanied by their relocation near the b cell area.
Changes of preferred territories of axons to innervate dur-
ing different ontogenetic stages are common. Transitory
targets are used by growing axons while waiting for their
definitive target to reach the maturity needed to receive
innervation. This might happen in the pancreas since the
innervation enters later to the b cell compartment, when
these cells display more mature functional features [26];
in P28 through adulthood. Adult mice also show more
sympathetic fibres located in the periphery of their islets
[16].
An interesting issue that deserves consideration relates to
the mechanism by which the sympathetic innervation is
remodelled. Previous observations that show that NGF
overexpression in transgenic mice [18] and knocking out
NGF and BAX [20] led to hyper-innervation and hypo-
innervation, respectively, strongly suggest that changes in
NGF availability might underlie sympathetic nerve
remodelling. Accordingly, our results show that insular
cells synthesize and release higher amounts of NGF at F19
and P1 than at P20 and after. Interestingly, this pattern of
NGF secretion closely paralleled the phases of hyper- and
hypo-innervation described in this work.
Model to explain the possible role of NGF in pancreatic development Figure 8
Model to explain the possible role of NGF in pancreatic development. Our results show that at foetal, early posnatal 
and P20 stages, the islets are immature in morphology and function. We observed that vasculature is formed first, followed by 
the innervation of sympathetic fibres and finally, by the capsule, finally conforming the architecture of the mature islet. Between 
P20 and adult stages a process of remodelling of the sympathetic innervation of the islet, probably by neural competition is 
observed. NFG could have a role in each the morphofunctional changes that can be received by insular cells, sympathetic fibres 
and blood vessels due to the presence to TrkA.BMC Developmental Biology 2009, 9:34 http://www.biomedcentral.com/1471-213X/9/34
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Further support for this type of inference is the fact that
TrkA-immunoreactivity was observed in islet sympathetic
fibres at all ages. We may speculate that the decrease in
NGF release in mature beta cells, might be the result of the
negative feedback of norepinephrine, secreted by mature
sympathetic fibres [40,41].
Conclusion
In conclusion, these morphological and functional data
suggest that NGF plays a pivotal role in pancreatic islet
morphogenesis, remodelling and maintenance of sympa-
thetic innervation and development of the vasculature
and maturation of a and b cells in the islets, as modelled
in Fig 8.
There is increasing evidence supporting the causal connec-
tion between many adult diseases and an altered ontog-
eny caused by persistent interactions between the
developing organism and its environment early during
pre- or postnatal life. A decrease in islet innervation has
been shown to be an early target in type 1 diabetes
[42,43]. Moreover, both homozygous knockout mice for
NGF and TrkA resulted in dramatic phenotypes showing
poor viability, not surviving beyond few weeks [44].
Interestingly in humans, an autosomal recessive mutation
in TrkA gene causes a syndrome of congenital insensitivity
to pain with anhydrosis (CIPA; [45], reviewed in [46]).
Patients with this mutation show an impaired first-phase
of glucose induced-insulin secretion [47]. Finally, a
decrease in serum NGF level has been associated with
peripheral neuropathy in animal models and humans
with diabetes [48,49].
Knowing the roles of NGF in pancreatic islet develop-
ment, maturation, innervation and function may lead us
to new perspectives for understanding and treatment of




The experiments were carried out in foetal (F19 day),
neonate (1 postnatal day; P1), juvenile (P20) and adult
Wistar rats. All postnatal rats were male, and born and
raised in temperature and light controlled rooms located
in our animal facility. Rats were weaned at P21 and
allowed free access to food and water after weaning. Ani-
mal protocols were designed following the guidelines pro-
vided by the Guide for the Care and Use of Laboratory
Animals (National Academy of Sciences, Washington
D.C., 1996) and approved by the Animal Care Committee
at the Instituto de Fisiología Celular, Universidad
Nacional Autónoma de México.
Culture of single insular cells
Rat foetuses were obtained through a caesarean incision at
the age 19 days of gestation. In all the experiments, ani-
mals were deeply anesthetised with sodium pentobarbital
(40 mg/kg of body weight). After this procedure, foetuses
were removed and placed in culture dishes filled with cold
D-MEM and rapidly, pancreas was dissected and animals
were killed by cervical dislocation.
A similar protocol was followed in rats of different post-
natal ages. Once pancreatic islets were obtained by colla-
genase digestion (collagenase type IV from Worthington;
Freehold, NJ), insular cells were desegregated and cul-
tured as described previously [13]. To improve dissocia-
tion, the suspension was passed through syringes with
needles of decreasing diameter. Dissociated cells were cul-
tured in 24-well culture dishes filled with RPMI 1640
(11.6 mmol/l glucose) supplemented with 10% foetal calf
serum, 200/ml penicillin G, 200 mg/ml streptomycin, and
0.5 mg/ml amphotericin B, at 37°C and 5% CO2 in air.
Islet cells were allowed to recover by culturing them over-
night before conducting further experiments. Reagents
were obtained from the following: Bovine serum albumin
(BSA), HEPES, poly-L-lysine, trypsin, from Sigma (St.
Louis, MO); tissue culture dishes from Corning (Corning,
NY); foetal bovine serum (FCS) from Equitech-BIO
(Ingram, TX); Hanks' balanced salt solution (HBSS),
RPMI 1640 salts, and penicillin-streptomycin-amphoter-
icin B solution from Life Technologies (Grand Island,
NY).
Immunofluorescence techniques
Fresh body-tail segments of rat pancreas were rapidly
placed in a buffered solution of paraformaldehyde (4%)
overnight at 4°C, washed in phosphate buffer-saline
(PBS; pH7.4, 0.1 M), and sequentially transferred to
graded (10, 20 and 30%) solutions of sucrose in PBS for
24 h in each concentration. Tissue samples were then
included in Tissue-Tek-II, cut longitudinally (5 or 10 mm)
in a cryostat (Leica CM 1900) and mounted on to gelatin-
coated slides. One tissue section was taken every 200 mm
along each pancreas segment.
Tissue sections and cultured cells were first incubated with
a blocking solution, with 2% bovine serum albumin (wt/
vol) and 0.1% Triton X-100 (vol/vol) in PBS-t during 30
min at room temperature. Cell and tissue samples were
then incubated with the primary polyclonal antibodies
raised against various neural, vascular and pancreatic anti-
gens and worked at different conditions (additional file
4); then washed and incubated with the corresponding
secondary antibodies conjugated to various fluorophores
(additional file 4). This allowed us to develop protocols
for single, double or triple immunofluorescence labelling.
After a final washing step with PBS, slides were cover-BMC Developmental Biology 2009, 9:34 http://www.biomedcentral.com/1471-213X/9/34
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slipped with anti-fading agent (DAKO). Negative controls
were designed as follows: pre-adsorption with the corre-
sponding antigen (1 mg peptide/mg antibody) for the anti-
bodies raised against NGF, insulin or glucagon. For the
rest of the antibodies, we omitted primary or secondary
antibodies.
To determine the percentage of cells positive to NGF,
TrkA, insulin and glucagon, at least 1400 culture cells were
counted per marker. Percentage of pancreatic islets that
display complete capsules were obtained at different
developmental stages, 100 islets were counted per stage.
Endothelial lectin-binding
Endothelial labelling was also achieved by incubating the
tissue sections with TRITC-conjugated Bandeiraea sim-
plicifolia I isolectin B4 (IB4; 45 ug/ml; Sigma), diluted in
PBS supplemented with 0.1 mg/ml CaCl2 and MgCl2
[22]. After an extensive wash, all of the slides were cover-
slipped with anti-fading mounting medium.
To further characterise blood vessels we used vimentin
that is an intermediate filament protein (IF). Vimentin is
expressed in cells of mesenchymal origin, like are
endothelial, fibroblasts and smooth muscle cells, all types
present in blood vessels [23,24]. We used a monoclonal
mouse Anti-Vimentin, Clone VIM 3B4, DAKO (see table
S1) according to the manufacturer's instructions.
Quantitative analysis of the sympathetic innervation
We measured islet innervation area at different stages, in
5 sections, taken each 100 mm in the pancreas, per animal
(n = 8 animals per data). In each section, 15 different islets
were measured. Each islet was delineated and TH+ cells
were removed from images using a computer based imag-
ing analysis system (Image J 1.36, Wayne Rasband;
National Institutes of Health, Bethesda, MD). The per-
centage of total pancreatic area and a and b areas occupied
by TH+ fibres were estimated. The total pancreatic area
was calculated by dividing TH+ fibres area by total pancre-
atic islet area, and a and b cell areas. The rate area TH+ =
area TH+ × 100/islet area (a cell area + b cell area).
Confocal microscopy
Confocal images were obtained using a Fluoview FV1000
laser confocal system (Olympus) attached/interfaced to
an Olympus IX81 inverted light microscope with a 40×
glycerol-immersion objective and some images were
obtained with zoom 2. We used an Olympus Fluoview
FV1000 confocal microscope to observe the sections for
Cy5 (excitation 647 nm/DF32, emission 680 nm/DF32),
CY3 (excitation 550 nm nm/DF32, emission 570 nm/
DF32) and FITC (excitation 488 nm/DF32, emission 522
nm/DF32).
For the semiquantitive immunoreactive pro-NGF analy-
sis, all images were taken with the exact same confocal set-
tings to obtain semi-quantitative fluorescent signal and
the histograms. Semi-quantification of image intensities
was done with Olympus FV10-ASW 1.4 software. Fluores-
cence measurements were performed automatically by the
computer program over the selected areas of interest. The
program measures the fluorescence signal of the cyto-
plasm of the insular cells and obtaining the mean fluores-
cence in function of the total number of pixels studied in
the islets.
Insulin and NGF secretion assays. After obtaining the
cells, 200 000 islet cells per well were incubated in Hanks'
balanced salt solution HBSS (5.6 mM glucose, 0.1% BSA)
for 1 hour at 37°C. Then, cells were clustered in three
experimental groups and incubated, in fresh 5.6 mM glu-
cose-HBSS, 15.6 mM glucose-HBSS or 15.6 mM glucose,
20 mM KCl in HBSS, for 1 hour at 37°C. At the end a pro-
tease inhibitors was added to each sample (Complete
Mini protease inhibitor cocktail; Roche Molecular Bio-
chemical, Mannheim, Germany). NGF and insulin con-
centrations were then measured by ELISA;
EmaxImmunoassay System (Promega, Madison, WI) for
NGF and Mercodia ultrasensitive rat insulin ELISA
(ALPCO, Windham, NH) for insulin. NGF and insulin
levels are reported in pg and ng respectively. All the results
were obtained by duplicate and normalised per mg of total
protein as estimated by using Bradford assays as recom-
mended by the supplier (Bio-Rad kit 500-0002).
Statistical analysis
All of the data are reported as means ± SEM; n denotes the
number of cells/or experiments. Because the data distribu-
tion fitted a normal curve, we used a one-way ANOVA fol-
lowed by a Bonferroni's test for multiple comparisons to
carry out the statistical analyses (Stat view 4.57; Abacus
Concepts, Cary, NC). The p value was set at 0.05.
Abbreviations
NGF: nerve growth factor; F19: foetal day 19; P0: postna-
tal day 0 or neonatal; P20: postnatal day 20
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